ਪ੍ਰਕਾਸ਼ਿਤ · Punjabi
China’s New Calibration Standard for Urine Meters: What Foreign MedTech Founders Need to Know
China’s market regulator has issued a new national metrology standard for urine meters used in ICUs, setting three evaluation dimensions and linking industry, hospitals, and regulators. Foreign founders in medical devices should understand how this affects product design, hospital use, and market access.
China’s New Calibration Standard for Urine Meters
On 27 October 2026, China’s State Administration for Market Regulation (SAMR) released a new national metrology technical specification: the Calibration Specification for Urine Meters (the “Specification”). The move fills a technical gap in China’s calibration regime for urine meters and strengthens metrology oversight in critical-care medicine. For foreign founders developing or selling medical devices in China, the Specification signals how regulators will assess urine meters and what hospitals will expect from suppliers.
The source is an official report from CCTV News, published via SAMR. This article summarises the facts and frames them as practical guidance for foreign entrepreneurs registering or operating a company in China.
Why urine meters matter in critical care
Urine output is a core indicator for assessing circulation and kidney function in critically ill patients. Urine meters are essential bedside monitoring devices in intensive care units (ICUs). They continuously collect and record patient urine output data, which doctors use to judge patient condition and adjust treatment plans. If measurement is inaccurate, it can easily lead to misjudgment of a patient’s condition and directly endanger the safety of critically ill patients.
Three evaluation dimensions set by the Specification
The Specification focuses on three metrological performance dimensions:
- Alarm function: Ensures the device can trigger audible and visual alarms when urine output is too high, too low, or when intermittent urine output exceeds preset thresholds. This helps medical staff quickly identify abnormal changes in a patient’s condition.
- Accuracy of total urine output indication: Assesses the device’s measurement performance for cumulative urine volume over a specified period. This ensures data stability and reliability during long-term continuous monitoring scenarios.
- Accuracy of intermittent urine output indication: Assesses the device’s measurement performance for cumulative urine volume within intermittent intervals. This ensures that real-time displayed or output urine data is accurate and traceable, providing solid and credible data support for clinical diagnosis.
How the Specification links industry, hospitals, and regulators
Once implemented, the Specification will connect three parties: industry, medical institutions, and metrology regulators.
- Industry side: Guides manufacturers to optimise product design against actual clinical conditions and strengthen factory metrological performance controls.
- Use side: Guides medical institutions to establish periodic traceability mechanisms for urine meters, reinforces the primary responsibility of medical units, and ensures daily metrological control of in-use devices.
- Regulatory side: Provides authoritative technical basis for market regulators to conduct metrological supervision inspections of medical devices, enabling full-chain metrological oversight from production to clinical use of critical-care devices.
Practical implications for foreign founders
For foreign founders active in medical devices, the Specification is more than a technical document—it is a signal of China’s tightening metrology supervision in critical-care equipment. If you plan to register a company in China and manufacture, import, or distribute urine meters, consider the following practical steps.
1. Align product design with the three dimensions
Review your device’s design and technical documentation to ensure it can meet the alarm function, total urine output accuracy, and intermittent urine output accuracy requirements. The Specification explicitly guides manufacturers to optimise product design against actual clinical conditions. Foreign founders should map their existing specifications against these dimensions early, especially if your product is already sold in other markets with different calibration norms.
2. Prepare for hospital traceability expectations
The Specification directs medical institutions to establish periodic traceability mechanisms for urine meters and to strengthen daily metrological control of in-use devices. If you supply devices to Chinese hospitals, you may need to provide calibration information, traceability documentation, and support for periodic verification. Building these into your after-sales and service model can help your hospital customers meet their responsibilities.
3. Understand the regulatory chain
The Specification provides a technical basis for market regulators to inspect medical devices. This means metrology supervision will cover the full chain from production to clinical use. Foreign founders should ensure that their China entity maintains proper metrology management, keeps records, and can demonstrate conformity if inspected. This is part of broader compliance for operating a company in China.
4. Factor the Specification into market access planning
While the source does not detail registration procedures, the new Specification adds a layer of technical expectation for urine meters in China. Foreign founders should consider how calibration requirements interact with product registration and hospital procurement. Engaging local metrology expertise early can reduce later friction.
5. Monitor implementation and local guidance
The source states the Specification was released on 27 October 2026. Implementation details and any transitional arrangements are not covered in the source. Foreign founders should watch for further guidance from SAMR and local market regulators, and consult qualified professionals on how the Specification applies to their specific devices.
Key takeaways for foreign founders
- China has issued a national metrology technical specification for urine meters, filling a calibration gap in critical-care monitoring.
- The Specification sets three evaluation dimensions: alarm function, total urine output accuracy, and intermittent urine output accuracy.
- It links manufacturers, hospitals, and regulators, with implications for product design, hospital traceability, and regulatory inspections.
- Foreign founders should review their device design, documentation, and service model against these dimensions before entering or expanding in the China market.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.
Foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535 for help registering and operating a company in China.